Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 200

1.

HIV seropositivity predicts longer duration of stay and rehospitalization among nonbacteremic febrile injection drug users with skin and soft tissue infections.

Hsieh YH, Rothman RE, Bartlett JG, Yang S, Kelen GD.

J Acquir Immune Defic Syndr. 2008 Dec 1;49(4):398-405.

PMID:
19186352
2.

Impact of HIV status on outcome of infectious complications in intravenous drug users.

Mertz D, Viktorin N, Wolbers M, Flückiger U, Battegay M.

J Acquir Immune Defic Syndr. 2009 Aug 1;51(4):506-7; author reply 507-8. doi: 10.1097/QAI.0b013e3181acb724. No abstract available.

PMID:
19590290
3.

[Injection site abscesses in intravenous drug users. Frequency of associated complications related to localisation].

Pfefferkorn U, Viehl CT, Bassetti S, Wolff T, Oertli D.

Chirurg. 2005 Nov;76(11):1053-7. German.

PMID:
15971034
4.

Community-acquired methicillin-resistant Staphylococcus aureus infections of the hand: prevalence and timeliness of treatment.

O'Malley M, Fowler J, Ilyas AM.

J Hand Surg Am. 2009 Mar;34(3):504-8. doi: 10.1016/j.jhsa.2008.11.021.

PMID:
19258149
5.

Baseline self-perceived risk of HIV infection independently predicts the rate of HIV seroconversion in a prospective cohort of injection drug users.

Wood E, Li K, Miller CL, Hogg RS, Montaner JS, Schechter MT, Kerr T.

Int J Epidemiol. 2005 Feb;34(1):152-8.

PMID:
15561747
6.

Staphylococcus aureus infections in injection drug users: risk factors and prevention strategies.

Bassetti S, Battegay M.

Infection. 2004 Jun;32(3):163-9. Review.

PMID:
15188077
7.

Risk factors for skin and soft-tissue abscesses among injection drug users: a case-control study.

Murphy EL, DeVita D, Liu H, Vittinghoff E, Leung P, Ciccarone DH, Edlin BR.

Clin Infect Dis. 2001 Jul 1;33(1):35-40.

PMID:
11389492
8.

National trends in ambulatory visits and antibiotic prescribing for skin and soft-tissue infections.

Hersh AL, Chambers HF, Maselli JH, Gonzales R.

Arch Intern Med. 2008 Jul 28;168(14):1585-91. doi: 10.1001/archinte.168.14.1585.

PMID:
18663172
9.

Severe soft tissue infections.

Napolitano LM.

Infect Dis Clin North Am. 2009 Sep;23(3):571-91. doi: 10.1016/j.idc.2009.04.006. Review.

PMID:
19665084
10.

Diagnostic and treatment options for skin and soft tissue abscesses in injecting drug users with consideration of the natural history and concomitant risk factors.

Khalil PN, Huber-Wagner S, Altheim S, Bürklein D, Siebeck M, Hallfeldt K, Mutschler W, Kanz GG.

Eur J Med Res. 2008 Sep 22;13(9):415-24.

PMID:
18948233
11.

High rates of primary care and emergency department use among injection drug users in Vancouver.

Kerr T, Wood E, Grafstein E, Ishida T, Shannon K, Lai C, Montaner J, Tyndall MW.

J Public Health (Oxf). 2005 Mar;27(1):62-6.

PMID:
15564279
12.

Soft tissue infections among injection drug users--San Francisco, California, 1996-2000.

Centers for Disease Control and Prevention (CDC)..

MMWR Morb Mortal Wkly Rep. 2001 May 18;50(19):381-4.

13.

Empiric antimicrobial therapy for pediatric skin and soft-tissue infections in the era of methicillin-resistant Staphylococcus aureus.

Elliott DJ, Zaoutis TE, Troxel AB, Loh A, Keren R.

Pediatrics. 2009 Jun;123(6):e959-66. doi: 10.1542/peds.2008-2428.

PMID:
19470525
14.

Skin and soft tissue infection: microbiology and epidemiology.

Dryden MS.

Int J Antimicrob Agents. 2009 Jul;34 Suppl 1:S2-7. doi: 10.1016/S0924-8579(09)70541-2. Review.

PMID:
19560670
15.

Skin and Soft Tissue Infections in Injection Drug Users.

Brown PD, Ebright JR.

Curr Infect Dis Rep. 2002 Oct;4(5):415-419.

PMID:
12228028
16.

Clinical profile of injection drug users presenting to the ED.

Kievlan DR, Gukasyan M, Gesch J, Rodriguez RM.

Am J Emerg Med. 2015 May;33(5):674-6. doi: 10.1016/j.ajem.2015.02.020.

PMID:
25744147
17.

Longitudinal predictors of injection cessation and subsequent relapse among a cohort of injection drug users in Baltimore, MD, 1988-2000.

Shah NG, Galai N, Celentano DD, Vlahov D, Strathdee SA.

Drug Alcohol Depend. 2006 Jun 28;83(2):147-56.

PMID:
16364568
18.

Correlates of health care utilization among HIV-seropositive injection drug users.

Mizuno Y, Wilkinson JD, Santibanez S, Dawson Rose C, Knowlton A, Handley K, Gourevitch MN; Inspire Team..

AIDS Care. 2006 Jul;18(5):417-25.

PMID:
16777632
19.

Emergency department utilization among a cohort of HIV-positive injecting drug users in a Canadian setting.

Fairbairn N, Milloy MJ, Zhang R, Lai C, Grafstein E, Kerr T, Wood E.

J Emerg Med. 2012 Aug;43(2):236-43. doi: 10.1016/j.jemermed.2011.05.020.

20.

Epidemiology and outcomes of complicated skin and soft tissue infections in hospitalized patients.

Zervos MJ, Freeman K, Vo L, Haque N, Pokharna H, Raut M, Kim M.

J Clin Microbiol. 2012 Feb;50(2):238-45. doi: 10.1128/JCM.05817-11.

Supplemental Content

Support Center